Atlas Trials

Tolerability of MDMA in Schizophrenia

Clinical trial NCT05770375 · RECRUITING

Trial details

NCT number
NCT05770375
Sponsor
Anya Bershad, MD, PhD
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2024-09-01
Primary completion
2027-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.